These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Radiation-induced cell cycle response in lymphocytes is not related to clinical side-effects in breast cancer patients.
    Author: Tell R, Edgren MR, Sverrisdottir A, Castro J, Fornander T, Hansson LO, Skog S, Lewensohn R.
    Journal: Anticancer Res; 2003; 23(3C):3077-83. PubMed ID: 12926165.
    Abstract:
    BACKGROUND: We examined whether development of radiation-induced lung injury after irradiation for breast cancer correlates with lymphocyte radiosensitivity (LRS) in vitro. MATERIALS AND METHODS: Patients were selected from a cohort of 177 patients, who were treated with adjuvant postoperative radiotherapy (RT) for loco-regional breast cancer, and included 14 patients who had severe early lung injury measured as respiratory symptoms caused by RT and treated with corticosteroids (i.e. "cases") and a corresponding 14 control patients without such symptoms. LRS was measured as the postirradiation fraction of mitogen-stimulated blood lymphocytes in S- and G2-phase. Plasma levels of TGF-beta 1 and thiols, both suggested to be involved in the pathogenesis of radiation-induced lung injury, were also analysed. RESULTS: The result showed that cells from the controls responded to a higher extent to mitogen stimulation than cells from the cases (p < 0.05). Analysis of the fraction of S- and G2-phase cells after irradiation showed no significant difference between the two groups (p = 0.57 and 0.31, respectively). There was no difference in plasma levels of TGF-beta 1 and thiols in patients who did or did not develop pulmonary injury after RT. Tamoxifen administered before or at RT did not influence the incidence of pulmonary reactions. CONCLUSION: No differences in LRS were found between breast cancer patients with lung complications after RT and matched control patients without complications.
    [Abstract] [Full Text] [Related] [New Search]